Basel Medical (BMGL) Gains from Investment Securities (2023 - 2024)
Basel Medical recorded quarterly Gains from Investment Securities of -$146055.0 in Q4 2024, up 30.96% quarter-over-quarter from -$211551.4 in Q4 2023, and up 30.96% year-over-year from -$111526.4 in Q1 2024.
Basel Medical's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$146055.0 for Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | Basel Medical | 8.57 Mn | 6.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -146,055.00 |
| Dec 31, 2024 | -146,055.00 |
| Dec 31, 2023 | -211,551.40 |
| Dec 31, 2023 | -211,551.40 |